News
Important health screenings can help you stay well
3+ hour, 7+ min ago (100+ words) Rockdale Citizen CONYERS " As Women's Health Month concludes," Piedmont Rockdale is encouraging women to prioritize preventive care, including routine screenings that help detect health risks early and support better long'term outcomes Stephanie Watson "Screenings prevent mortality for the specific conditions…...
Galleri blood test "feasible at scale" on NHS, say experts
1+ hour, 35+ min ago (898+ words) Annual screening with a blood test designed to detect multiple cancers before symptoms appear is "feasible at scale" on the NHS, according to experts. The NHS-Galleri trial is exploring how well the Galleri blood test works within the health service…...
FUW raises impressive sum for Prostate Cymru
1+ hour, 44+ min ago (306+ words) The Farmers" Union of Wales has presented a cheque for "1, 980 to Prostate Cymru following a successful fundraising dinner held in honour of renowned Welsh businessman and agricultural supporter Brian Jones, Castell Howell. The special dinner was organised to celebrate Brian…...
ENZAMET Trial Shows Veracyte's Decipher Prostate Test Identifies Which Patients Benefit from Adding Chemotherapy in Metastatic Prostate Cancer
2+ hour, 7+ min ago (259+ words) Study provides first Level 1 B evidence for genomic-guided decisions on triplet therapy in advanced disease Approximately 334, 000 men are diagnosed with prostate cancer annually in the United States, including about 30, 000 who present with metastatic disease at diagnosis. 2, 3 While recent treatment advances…...
ASCO 2026: Skipping axillary lymph node dissection safe for some breast cancer patients
6+ hour, 48+ min ago (322+ words) Oncology Central is part of Taylor & Francis Group. Original story from the ASCO Annual Meeting The trial included 2, 540 people with T1 to T3 breast cancer and up to 2 sentinel lymph node macrometastases. T1 to T3 tumors have not grown into the chest wall or…...
Pfizer Says Talzenna Plus Xtandi Improves Radiographic Progression-Free Survival By Over 50% In Metastatic Prostate Cancer
8+ hour, 1+ min ago (39+ words) Trading View Pfizer Says Talzenna Plus Xtandi Improves Radiographic Progression-Free Survival By Over 50% In Metastatic Prostate Cancer More news from Reuters...
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
3+ hour, 23+ min ago (800+ words) First PARP inhibitor + ARPI combination to show consistent r PFS improvement in HRR gene'altered metastatic hormone'sensitive prostate cancer, including both BRCA and non'BRCA alterations There was an estimated 77% probability of remaining progression-free at three years with TALZENNA plus XTANDI Detailed…...
Low Testosterone May Predict High-Grade Prostate Cancer
8+ hour, 7+ min ago (267+ words) MEN with low baseline testosterone undergoing active surveillance (AS) for localised prostate cancer may face a greater risk of developing higher-grade disease, according to a new retrospective cohort study. Researchers evaluated 924 men enrolled in an AS programme between 2005 and 2024 to…...
ASCO26: Talzenna-Xtandi regimen halves risk of progression, death in prostate cancer
8+ hour ago (14+ words) First Word Pharma...
Has Alumis's Envudeucitinib Redefined Psoriasis Treatment
18+ hour, 4+ min ago (700+ words) Kavout Has Alumis's Envudeucitinib Redefined Psoriasis Treatment - Alumis's Envudeucitinib delivered robust Phase 3 results in plaque psoriasis, showcasing strong skin clearance and quality of life improvements. - The drug's differentiated profile, including superior efficacy against apremilast and maximal 24-hour TYK2 inhibition, positions it…...